MyFinsight
Home
About
Contact
mbrx: the income statement
Download
Download image
Comprehensive loss
-$25,405K
(-140.17%↓ Y/Y)
Foreign currency
translation
-$6K
(-142.86%↓ Y/Y)
Net loss
-$25,399K
(-139.79%↓ Y/Y)
Interest income, net
$39K
(-61.76%↓ Y/Y)
Other income, net
$16K
(77.78%↑ Y/Y)
Gain from change in
fair value of warrant...
-$1,591K
(-192.07%↓ Y/Y)
Loss on issuance of
warrant liabilities
-$20,609K
(-2333.18%↓ Y/Y)
Transaction costs allocated
to warrant...
$530K
(-46.63%↓ Y/Y)
Loss from operations
-$5,906K
(17.22%↑ Y/Y)
Total operating
expenses
$5,906K
(-17.22%↓ Y/Y)
Depreciation and
amortization
$21K
(-32.26%↓ Y/Y)
General and
administrative
$2,147K
(-1.15%↓ Y/Y)
Research and development
$3,738K
(-24.21%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech, Inc. (MBRX)